Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection

A New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by in vitro Exposure to Letermovir and Ganciclovir

(2018) Sunwen Chou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

(2018) Camille N. Kotton et al.   TRANSPLANTATION

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

(2017) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance

(2016) Lena Fischer et al.   ANTIVIRAL RESEARCH

Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis

(2016) D. Andouard et al.   ANTIVIRAL RESEARCH

RapidIn VitroEvolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance

(2015) Sunwen Chou   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)

(2015) Peter Lischka et al.   JOURNAL OF INFECTIOUS DISEASES

Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants SelectedIn Vitroafter Letermovir (AIC246) Exposure

(2013) Thomas Goldner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation

(2013) Lena Fischer et al.   ANTIVIRAL RESEARCH

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study

(2013) Susanne Stoelben et al.   TRANSPLANT INTERNATIONAL

First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246

(2011) D. R. Kaul et al.   AMERICAN JOURNAL OF TRANSPLANTATION